The board meeting for Neurocrine Biosciences, Inc. is scheduled for today, for the purpose of TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry and Epilepsy Virtual SummitSee details
Neurocrine Biosciences, Inc. - NBIX - stock price prediction, stock price target, analyst ratings from 26 analysts
Neurocrine Biosciences, Inc. has a share price target of US$ 168, revenue growth forecast of 18.5%, and profit growth estimate of 31.0% for FY25, based on top 26 analyst calls.